Rating History for Entera Bio (ENTX) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/25/2026 | Vamil Divan | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.81 (3.17) |
12.81% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/25/2026 | Vamil Divan | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.81 (3.17) |
12.81% | Details |